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Abstract
Postprandial inflammation is an important factor for human health since chronic low-grade inflammation is associated with chronic diseases.
Dairy products have a weak but significant anti-inflammatory effect on postprandial inflammation. The objective of the present study was to
compare the effect of a high-fat dairy meal (HFD meal), a high-fat non-dairy meal supplemented with milk (HFM meal) and a high-fat non-dairy
control meal (HFC meal) on postprandial inflammatory and metabolic responses in healthy men. A cross-over study was conducted in nineteen
male subjects. Blood samples were collected before and 1, 2, 4 and 6 h after consumption of the test meals. Plasma concentrations of insulin,
glucose, total cholesterol, LDL-cholesterol, HDL-cholesterol, TAG and C-reactive protein (CRP) were measured at each time point. IL-6, TNF-a
and endotoxin concentrations were assessed at baseline and endpoint (6 h). Time-dependent curves of these metabolic parameters were
plotted, and the net incremental AUC were found to be significantly higher for TAG and lower for CRP after consumption of the HFM meal
compared with the HFD meal; however, the HFM and HFD meals were not different from the HFC meal. Alterations in IL-6, TNF-a and
endotoxin concentrations were not significantly different between the test meals. The results suggest that full-fat milk and dairy products
(cheese and butter) have no significant impact on the inflammatory response to a high-fat meal.
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Immune and metabolic response systems in humans are closely
linked due to an evolution from common ancestral structures.
However, what may have been beneficial in the past may be
detrimental under the current Western lifestyle favouring over-
nutrition combined with malnutrition as well as low physical
activity(1). After food intake, inflammatory markers in the
systemic circulation transiently increase as a reaction to the
acute ingestion of nutrients. This effect, known as postprandial
inflammation, is a normal metabolic response of the organism to
regulate energy expenditure after the ingestion of food(2) and to
safeguard immunological homeostasis. However, postprandial
inflammation has become an important factor for human
health since people in industrialised countries are almost
constantly in a postprandial state, and postprandial inflam-
mation may thus turn into chronic low-grade inflammation(3).
Chronic low-grade inflammation is known to be associated
with atherosclerosis and type 2 diabetes(4,5). Metabolic
disorders such as obesity, characterised by a chronic low-
grade inflammation in the fasting state, increase the magnitude
of postprandial inflammation(6).
Several nutrient-dependent factors influence the degree of
postprandial inflammation induced by a meal: (1) its energy
value; (2) the amount of carbohydrates and the glycaemic index;
(3) the amount and composition of lipids(4). High-fat meals
increase the postprandial concentrations of pro-inflammatory
cytokines IL-6 and TNF-a, and augment the hepatic
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production of acute-phase proteins such as C-reactive protein
(CRP)(7–9). Additionally, high-fat meals influence postprandial
metabolism by increasing glucose, insulin and TAG concen-
trations(10,11). We previously demonstrated a dose–response
for glucose, insulin, TAG and IL-6 concentrations after the
consumption of three energy doses (2092, 4184 and 6276 kJ
(500, 1000 and 1500 kcal)) of the same high-fat meal in
normal-weight and obese men(12).
Results of various studies indicate that foods rich in phyto-
chemicals, such as orange juice and tomatoes, are able to
reduce postprandial inflammation(13,14). Furthermore, obser-
vational studies have suggested that a high intake of dairy
products can be negatively associated with low-grade systemic
inflammation(15–18). In most Western countries, dairy products
play an important role in the normal human diet. As these
products have been associated with beneficial effects on
weight and body fat(19), a positive influence on postprandial
inflammation would be an additional asset. However, clinical
studies evaluating the impact of dairy product consumption
on systemic inflammation in overweight and obese men and
women, with interventions between 4 and 48 weeks, have
yielded differing results. For example, half of the studies
suggested a beneficial effect of dairy product intake on systemic
inflammation, and the other half found no effect(20). Only one
study has investigated the impact of dairy products on post-
prandial inflammation: Nestel et al.(21) documented a significant
drop in inflammatory markers in overweight participants 3 h
after consumption of meals composed of cream, butter or
low-fat milk, but not after consumption of cheese or yogurt.
Most parameters returned to baseline concentrations at 6 h,
and no differences between groups were observed.
The aim of the present study was to investigate the effect of
full-fat milk and dairy products on postprandial inflammatory
and metabolic responses in healthy men. In particular, two
questions were addressed. (1) Does a high-fat meal composed
of dairy products induce a lower postprandial inflammatory
response than a comparable non-dairy high-fat meal? (2) Does
the addition of milk reduce the inflammatory response of
a non-dairy high-fat meal? IL-6 determined at 6 h after the
meals was chosen as the primary endpoint of the present study.
Materials and methods
Study population
A total of twenty-one male volunteers were recruited by
advertisements on the Internet and with flyers at the Division
of Endocrinology, Diabetes and Clinical Nutrition, University
Hospital of Bern, and at Agroscope between May and
August 2013. Subjects had to meet the following inclusion
criteria: male; aged 25–55 years; BMI $20 kg/m2; willingness
to keep dietary habits and physical exercise constant during
the study. Normal-weight as well as overweight and obese
participants were included to reflect population composition
in Switzerland. In addition, our previous study(12) showed
no differences between normal-weight and obese participants
in the postprandial response of IL-6. The exclusion criteria
were smoking, following a vegetarian or vegan diet, infectious
disease, acute or chronic pharmaceutical intake, marked
dyslipidaemia, food allergy or intolerance, diabetes, existing
physical or mental disease, or simultaneous participation in
another study. Body weight and height were assessed at
inclusion, and written informed consent was obtained from
all subjects. The present study was conducted according to
the guidelines laid down in the Declaration of Helsinki, and
was approved by the Cantonal Ethical Committee of Bern,
Switzerland. The trial was registered at ClinicalTrials.gov
(NCT01885416).
Study design and diet
In the present prospective, randomised cross-over study,
participants were assigned to three different high-fat meals
in random order. Meal intake was separated by washout
periods of at least 1 week during which participants consumed
their usual diet. Volunteers arrived at the University Hospital of
Bern after an overnight fasting of at least 8 h, on the mornings
of the study days. Baseline fasting blood samples were
collected for the determination of the metabolic and inflam-
matory parameters described below. Participants were then
requested to consume the assigned meals within 30 min. The
meals were prepared ahead by the study investigators and
consumed under their supervision. At time points 1, 2, 4 and
6 h after the end of the meal intake, blood samples were
taken for the determination of blood parameters. Participants
were not allowed to consume any food or beverages for 6 h
after meal intake, except for 1 litre of still mineral water.
Subjects consumed the following three meals: (1) HFC meal
(high-fat non-dairy control meal; 4204 kJ (1005 kcal));
(2) HFD meal (isoenergetic high-fat dairy meal; 4184 kJ
(1000 kcal)); (3) HFM meal (high-fat non-dairy meal
supplemented with milk; 5343 kJ (1277 kcal)). The HFC meal
consisted of bread (120 g), salami (100 g), palm fat (26 g),
hard-boiled egg (50 g) and still mineral water (400 ml). The
HFD meal contained bread (120 g), cheese (Teˆte de Moine;
110 g), butter (25 g), mozzarella cheese (32 g) and still mineral
water (400 ml). The HFM meal was similar to the control meal,
but whole-fat milk (400 ml) was given instead of still mineral
water. All food except palm fat was bought at a local store
of a Swiss supermarket chain. Palm fat was obtained from a
local health food shop. The control meal was adopted from
our previously conducted study investigating the impact of
high-fat meals with the same macronutrient composition but
different energy content on inflammatory and metabolic
responses in obese and normal-weight subjects(12). The nutri-
ent composition of the three meals was calculated with Prodiw
5.8 (Nutri-Science GmbH), and is presented in Table 1. Due to
the obvious differences between the three meals, it was not
possible to blind the investigators or study participants.
Blood sampling and analyses
Blood samples were taken using an indwelling peripheral
venous catheter (Vasofixw Safety; B. Braun Melsungen AG).
Fasting blood samples were obtained before each meal to
determine the concentrations of CRP, IL-6, TNF-a, endotoxin,
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insulin, glucose and lipids (total cholesterol, LDL-cholesterol,
HDL-cholesterol and TAG). Non-fasting blood samples were
collected 1, 2, 4 and 6 h after each meal. Lipid, insulin and
glucose concentrations were determined at each time point,
while IL-6, TNF-a and endotoxin concentrations were deter-
mined only at 6 h.
Blood samples for serumanalyseswere collected in serum-gel
S-Monovettew (Sarstedt AG & Co.), and blood samples for
plasma analyses were collected in plasma-gel S-Monovettew
with lithium heparin (Sarstedt AG & Co.). Assays for insulin
(serum), glucose, lipids and CRP (plasma) were immediately
performed in the chemistry laboratory of the University Hospital
Inselspital Bern. Insulin was measured by an electrochemi-
luminescence sandwich immunoassay (Modular E170; Roche),
glucose by enzymatic determination with hexokinase
(Modular P800; Roche), high-sensitivity CRP with an immune
turbidimetric test enhanced with latex particles (Modular P800;
Roche), TAG with the GPO-PAP method (Modular P800;
Roche), cholesterol with the CHOD-PAP method (Modular
P800; Roche), and HDL-cholesterol with an enzymatic test for
direct quantitative determination (Modular P800; Roche).
Plasma for IL-6, TNF-a and endotoxin determination was
separated by centrifugation (2000 g for 10 min), split into
Eppendorf tubes, frozen at 2208C and stored at 2808C until
later analysis. IL-6 and TNF-a concentrations were measured
with a high-sensitivity multiplex cytokine assay (Bio-Plexw
System; Bio-Rad). The sensitivity of the kit, as provided by the
manufacturer, was 0·2 pg/ml. The intra-assay CV was 5 %, and
the inter-assay CV was 10 %. Endotoxin was measured with a
commercially available QCL-1000 LAL EndPoint Assay (Lonza).
This assay has previously been validated for human serum. It
showed an intra-assay CV of 3·9 (SD 0·5) % and an inter-assay
CV of 9·6 (SD 0·8) %. Recovery rate for spiked endotoxin was
82·0 (SD 3·3) %(22).
Statistical analyses
Statistical analyses were performed using Systat 13.0 (Systat
Software, Inc.) and R version 2.15.2 (R Foundation for Statistical
Computing)(23) with the R package non-parametric longitudi-
nal data (nparLD) and R package R Commander. Sample
size was estimated with a power analysis for a 2 £ 2 cross-
over design(24) based on the data of a previous study with
high-fat meals(12). For a desired significance level of P#0·05
and 80 % power to detect a within-subject difference of
1·265 pg/ml for IL-6 (primary endpoint), a sample size of
eighteen was necessary.
Data are presented as means and standard deviations,
unless otherwise indicated. The R package nparLD, function
ld.f1, was applied to compare values at time points 1, 2, 4
and 6 h with baseline values. To evaluate the overall response
of metabolic parameters during the 6 h postprandial period,
the net incremental AUC (net iAUC) was calculated. The net
iAUC subtracts the negative iAUC from the positive iAUC,
which are the areas of excursion below and above the
baseline values, respectively, by using the trapezoid method.
To investigate whether there was an overall significant post-
prandial effect, the following null hypothesis was tested by
Wilcoxon signed-rank test H0: net iAUC ¼ 0. The net iAUC
was chosen to minimise biologically irrelevant deviations
from the baseline values that would otherwise be taken into
consideration by calculating only the positive iAUC(12).
Wilcoxon signed-rank tests were also used on the net iAUC
values for the pairwise comparison of the three test meals.
Changes in the concentrations of IL-6, TNF-a and endotoxin
between baseline and 6 h were calculated by subtracting fast-
ing concentrations from values at 6 h. The R package nparLD
was applied to compare these values. Since previous investi-
gations suggested differences in the postprandial metabolic
and inflammatory response of subjects with higher and
lower BMI, study participants were grouped by BMI (#25
v. .25 kg/m2) for further statistical analyses. The robust
non-parametric Kruskal–Wallis test was used to evaluate
differences between the test meals and between the BMI
subgroups for significance. Differences were considered
statistically significant at P#0·05.
Results
In total, twenty-one subjects were enrolled in the present
study. Of these, one subject withdrew after the first study
day because of scheduling conflicts, and one subject was
retrospectively excluded due to hypercholesterolaemia; thus,
a final sample of nineteen subjects were included in the
analysis. Study participants were males with a mean age of
41·8 (SD 9·0) years and a mean BMI of 27·1 (SD 8·2) kg/m2.
Fasting concentrations of blood parameters before each
meal are presented in Table 2. There were no differences in
these parameters between the test meals.
The subgroup with BMI #25 kg/m2 included eleven partici-
pants with a mean age of 39·7 (SD 10·5) and a mean BMI of
22·4 (SD 1·6) kg/m2. The subgroup with BMI .25 kg/m2
included eight participants with a mean age of 44·7 (SD 5·8)
years and a mean BMI of 33·6 (SD 9·3) kg/m2.
Fig. 1 shows the mean changes in the metabolic parameters
after consumption of the three meals, over 6 h. Detailed
information can be found in online Supplementary Table S1.
Table 1. Nutrient composition of the meals used in the study
HFC meal HFD meal HFM meal
Energy (MJ) 4·1 4·2 5·3
Protein
g 41·4 43·6 54·6
E% 17 18 17
Carbohydrate
g 55·0 55·0 74·0
E% 22 22 23
Fat
g 67·0 67·0 84·0
E% 61 60 60
SFA (g) 26·5 39·7 36·5
MUFA (g) 28·6 16·1 32·5
PUFA (g) 7·6 3·6 8·4
Ca (mg) 73 924 525
HFC meal, high-fat non-dairy control meal; HFD meal, high-fat dairy meal; HFM
meal, high-fat non-dairy meal supplemented with milk; E%, percentage of
energy.
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Insulin significantly increased at 1 h after intake of all the test
meals and decreased to below baseline values at 6 h. Glucose
showed the same pattern, but increases at 1 h were significant
only after the intake of the HFD and HFM meals. Furthermore,
TAG significantly increased in the 4h period following ingestion
of the three test meals. In contrast, LDL- and HDL-cholesterol
significantly decreased in the same time period. The mean
net iAUC of glucose, insulin, total cholesterol, LDL- and
HDL-cholesterol, total cholesterol:HDL-cholesterol, LDL-
cholesterol:HDL-cholesterol, TAG and CRP for each meal are
presented in Table 3. A significantly lower net iAUC was
shown for TAG, and a significantly higher net iAUC was shown
for CRP, after ingestion of the HFD meal compared with the
HFM meal (P¼0·02, for both). There were no other significant
differences in metabolic parameters between the three meals.
No meal effect on the net iAUC was detected within the two
BMI subgroups for any metabolic parameter (data not shown).
Mean changes in IL-6, TNF-a and endotoxin concentrations
between baseline and 6 h for each meal are presented in
Table 4. IL-6 increased at 6 h after ingestion of all the three
test meals, although this increase was only significant after
the HFC and HFD meals, not after the HFM meal. Also, alte-
rations in IL-6 did not differ between the three test meals.
TNF-a concentration decreased after ingestion of all the
three test meals, but was only significantly lower in the HFD
meal at 6 h compared with baseline values (see online
Supplementary material). A significant reduction in TNF-a
concentration after the HFD meal was observed in the
subgroup of subjects with BMI #25 kg/m2. In this subgroup,
a significant (P¼0·02) difference between the three meals
was observed with a greater decrease in TNF-a concentration
after the HFD meal (20·68 pg/ml) compared with the other
two meals (HFC meal: 20·16pg/ml, HFM meal: 20·29pg/ml).
This effect was not found in the subgroup of subjects with
BMI . 25 kg/m2. Finally, endotoxin concentration signifi-
cantly increased between baseline and 6 h after ingestion of
all the three test meals; however, the magnitude of these
increases did not differ between the three test meals.
Discussion
The aim of the present study was to investigate the effect of
dairy products on metabolic and inflammatory responses to
a high-fat meal. Specifically, we examined whether the HFD
meal results in a lower postprandial inflammatory response
than does the HFC meal, and whether the addition of milk
to the HFC meal yields a lower inflammatory response than
does the HFC meal alone. The differences identified between
the three meals were inconsistent and of small magnitude. In
the HFC meal, IL-6 was significantly increased, TNF-a did not
show significant differences and CRP was significantly
decreased at 6 h compared with baseline. In the HFD meal,
IL-6 was significantly increased, TNF-a was significantly
decreased and CRP was not different at 6 h compared with
baseline. In the HFM meal, IL-6 and TNF-a did not show sig-
nificant differences and CRP was significantly decreased at 6 h
compared with baseline. In agreement with the low magni-
tude of these changes in pro-inflammatory markers, there
were no statistically significant differences between the three
test meals. Thus, we conclude that the HFD and HFM meals
were comparable with the HFC meal in regard to postprandial
inflammation. The two questions presented in the introduc-
tion (does a high-fat meal composed of dairy products
induce a lower postprandial inflammatory response than a
comparable non-dairy high-fat meal? and does the addition
of milk reduce the inflammatory response of a non-dairy
high-fat meal?) were thus not affirmed by the study.
Although no significant differences between the test meals
were detected, the results within groups suggest that in con-
trast to cheese and butter, whole-fat milk may have a positive
effect on postprandial inflammation induced by a high-fat
meal because none of the three inflammatory cytokines was
significantly increased after the HFM meal, although it had
30 % higher energy content compared with the HFC meal.
Congruently, in the investigation by Nestel et al.(21), the
intake of low-fat milk but not cheese in a high-fat meal with
comparable energy resulted in significantly decreased IL-6
and TNF-a concentrations. In contrast, butter, which was
Table 2. Fasting concentrations of blood parameters before each meal*
(Mean values and standard deviations)
HFC meal HFD meal HFM meal
Mean SD Mean SD Mean SD
Glucose (mmol/l) 5·0 0·4 5·0 0·5 5·1 0·4
Insulin (mU/l)† 9·8 8·8 9·5 6·5 9·7 8·1
Total cholesterol (mmol/l) 5·0 0·6 5·1 0·8 5·3 0·9
LDL-cholesterol (mmol/l) 3·4 0·7 3·4 0·8 3·6 0·9
HDL-cholesterol (mmol/l) 1·4 0·3 1·4 0·4 1·4 0·4
TAG (mmol/l) 1·4 0·7 1·3 0·8 1·5 0·8
Total cholesterol:HDL-cholesterol 3·8 1·2 3·9 1·4 4·0 1·3
LDL-cholesterol:HDL-cholesterol 2·6 1·0 2·6 1·1 2·8 1·1
CRP (mg/l) 1·2 1·2 1·4 1·6 1·8 1·5
IL-6 (pg/ml) 3·0 1·1 3·7 2·6 3·9 2·9
TNF-a (pg/ml) 3·6 1·3 3·6 1·3 3·6 1·5
Endotoxin (EU/ml) 2·3 0·8 2·3 0·7 2·4 0·8
HFC meal, high-fat non-dairy control meal; HFD meal, high-fat dairy meal; HFM meal, high-fat non-dairy meal supplemented with milk; CRP,
C-reactive protein; EU, endotoxin units.
* There were no significant differences in baseline variables between the test meals.
† To convert insulin in mU/l to pmol/l, multiply by 6·945.
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also part of our HFD meal, also decreased IL-6, TNF-a and
CRP concentrations in the study by Nestel et al.(21). However,
a comparison of the findings is difficult because their results
were documented at 3 h but not at 6 h after meal intake. The
fasting IL-6 and TNF-a concentrations in overweight partici-
pants in the study by Nestel et al.(21) were much higher than
those observed in the present study (online Supplementary
Table S1). In that context, Schwander et al.(12) reported that,
apart from insulin, an energy dose–response relationship
was necessary to differentiate the postprandial metabolic
response of obese subjects from that of normal-weight
subjects. Studies aimed at quantitatively differentiating the
acute response of human subjects to the ingestion of different
foods should thus take several key factors into account,
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Fig. 1. Postprandial changes in the investigated metabolic parameters (glucose (a), insulin (b), total cholesterol (c), TAG (d), LDL-cholesterol (e), HDL-cholesterol
(f) and C-reactive protein (CRP) (g)) after the three meals. Postprandial kinetics of healthy male subjects in response to the ingestion of a high-fat non-dairy
control meal (–V–), a high-fat dairy meal (- -B- -) and a high-fat non-dairy meal supplemented with milk (–O–). Values are means, with their standard errors
represented by vertical bars. To convert insulin in mU/l to pmol/l, multiply by 6·945.
Dairy products and postprandial inflammation 1857
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
in particular the energy dose–response effects of the ingested
meal and the detailed kinetics of the postprandial response.
Since several studies have suggested an anti-inflammatory
effect of dairy products(20), it remains to be clarified why the
HFD meal did not exert a positive effect in regard to the post-
prandial inflammatory response and why full-fat milk may
yield deviating results. Dietary components such as Ca and
dairy proteins have been suggested as causes of the anti-
inflammation effect of dairy products. In a mouse study,
high-Ca and milk diets suppressed the gene expression of
inflammatory cytokines (IL-6 and TNF-a) in adipose tissue
compared with a basal diet(25). However, in the present
study, Ca intake (Table 1) did not correlate with inflammatory
markers, as Ca intake was highest with the HFD meal.
Furthermore, the milk protein lactoferrin has been shown to
modulate the inflammatory process by influencing the recruit-
ment and activation of cytokine-releasing immune cells(26). In
an in vitro study with bovine lactoferrin and lactoferricin, the
latter being a bactericidal pepsin-derived fragment of the
former, both proteins suppressed the release of IL-6 by
human monocytic cell lines stimulated with lipopolysacchar-
ide. Lactoferricin was even more potent than lactoferrin, and
the inhibition was stronger, when the suppressors were
added before the stimulation with lipopolysaccharide(27). Lac-
toferrin is found in milk but not in cheese because it is lost
with the whey during the cheese production process. There-
fore, lactoferrin and its fragments in milk may be responsible
for mitigating the inflammatory response to the HFM meal
compared with the HFD meal. A reason for the inflammatory
response after the consumption of the HFD meal might be the
choice of cheese. Subsequent analyses of Teˆte de Moine
cheeses that were part of the HFD meal revealed, in most
samples, rather high concentrations of biogenic amines
(mean 891 (SD 194) mg/kg), especially histamine and
tyramine. Histamine was found to enhance the secretion of
various pro-inflammatory cytokines, including IL-6 and
TNF-a, over the H4R receptor in human mast cells(28). The
first intolerance symptoms can occur with ingestion of
10–50 mg histamine(29). Since the HFD meal contained on
average 58·5 mg histamine, this may have abolished the
potential positive effects of other dairy constituents.
Endotoxin (bacterial lipopolysaccharide) in the circulation
activates the immune system and is recognised as a main
trigger for the inflammatory response. In animal and human
studies, lipopolysaccharide concentrations correlated with fat
consumption(12,30,31). Therefore, the pro-inflammatory effect
of high-fat meals may be linked to the translocation of endo-
toxin from the gut into the circulation. In the present study,
significantly (P,0·001) increased endotoxin concentrations
were measured at 6 h after all the three high-fat meals with
no difference between the meals (Table 4), although the
HFM meal had a slightly higher fat content. The percentage
of endotoxin increase over the baseline values in the present
study is similar to the findings of previous studies of healthy
males consuming 3766 kJ (900 kcal) of a high-fat meal(13,32).
High postprandial TAG values have been shown to induce
higher numbers of circulating inflammatory cells, as well as to
activate them, thus promoting a systemic pro-inflammatory
status(3,33). Glucose increases the expression of inflammatory
parameters such as TNF-a and IL-6, whereas insulin has
anti-inflammatory effects(34). Therefore, the metabolic effects
of meals are important components in postprandial inflam-
mation. The metabolic response documented in the present
study is comparable with other reports(12,35,36). Insulin
and glucose increased in the first hour after meal intake and
then decreased to below baseline values at 6 h. TAG increased
in the 4 h following the three test meals, whereas LDL- and
HDL-cholesterol decreased in the same period. With the
Table 4. Effects of the three test meals on changes in blood
parameters from baseline to 6 h
(Mean values and standard deviations)
HFC meal HFD meal HFM meal
Mean SD Mean SD Mean SD
IL-6 (pg/ml) 2·1*** 2·6 1·3** 2·8 1·6 4·5
TNF-a (pg/ml) 20·2 0·4 20·4*** 0·5 20·2 0·6
Endotoxin (EU/ml) 1·0*** 1·0 0·9*** 0·9 1·3*** 0·9
HFC meal, high-fat non-dairy control meal; HFD meal, high-fat dairy meal; HFM
meal, high-fat non-dairy meal supplemented with milk; EU, endotoxin units.
Mean value was significantly different from zero: **P#0·01, ***P#0·001.
Table 3. Postprandial effects of the three test meals on blood parameters expressed as net incremental AUC
(Mean values and standard deviations)
HFC meal HFD meal HFM meal
Mean SD Mean SD Mean SD
Glucose (mmol/l £ 6 h) 21·4* 2·2 20·9 2·3 21·2* 1·9
Insulin (mU/l £ 6 h)† 76·5*** 78·7 93·6*** 107·5 85·0*** 75·8
Total cholesterol (mmol/l £ 6 h) 20·5 1·2 20·6* 1·1 21·0*** 0·8
LDL-cholesterol (mmol/l £ 6 h) 21·2*** 0·7 21·2*** 0·6 21·5*** 0·6
HDL-cholesterol (mmol/l £ 6 h) 20·5*** 0·4 20·5*** 0·4 20·6*** 0·4
TAG (mmol/l £ 6 h) 5·4***a,b 2·5 4·9***a 2·6 6·3***b 3·1
CRP (mg/l £ 6 h) 20·3**a,b 0·3 20·04b 0·5 20·5***a 0·6
HFC meal, high-fat non-dairy control meal; HFD meal, high-fat dairy meal; HFM meal, high-fat non-dairy meal supplemented with
milk; CRP, C-reactive protein
a,b Mean values within a row with unlike superscript letters were significantly different (P#0·05).
Mean value was significantly different from zero: *P#0·05, **P#0·01, ***P#0·001.
† To convert insulin in mU/l to pmol/l, multiply by 6·945.
A. Schmid et al.1858
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
exception of TAG, the net iAUC of all metabolic parameters did
not significantly differ between themeals,which is probably due
to the matching macronutrient composition of the test meals.
The net iAUC of TAG was significantly higher in the HFM meal
than in the HFD meal, but not in the HFC meal. Since the
amount of fat intake has an impact on postprandial TAG
concentration(37,38), the elevated fat content of the HFM meal
may be the reason for the significantly higher net iAUC.
However, the net iAUC was only significantly different
comparedwith theHFDmeal, notwith theHFCmeal. Therefore,
an additional factor may be involved. One reason might be that
the high Ca content of a meal promotes faecal fat excretion
through the binding of Ca to fatty acids in the intestine(39,40).
The HFD meal had the highest Ca concentration of the three
test meals (HFD: 924 mg, HFC: 73 mg, HFM: 525 mg). In
addition, the HFD meal contained dairy fat with substantial
amounts of SCFA and medium-chain fatty acids that have a
limited effect on postprandial TAG concentration(38). Both
factors may explain the marginally lower net iAUC of TAG
compared with the HFC meal, eventually adding up to a signifi-
cant difference compared with the HFM meal.
Previous studies have reported a positive correlation
between endotoxin and TAG levels after ingestion of high-fat
meals(12,30,41) and a consequential elevation of inflammatory
markers such as IL-6(31). We have confirmed these observations
in the present study, as the increase in plasma endotoxin
concentration 6 h after consumptionof thehigh-fatmeals signifi-
cantly and positively correlated (r 2 0·62) with the increase in
TAG concentration over the same period of time (data not
shown). However, despite a significantly higher postprandial
net iAUC of TAG for the HFM meal than for the HFD meal, the
inflammatory cytokine and endotoxin concentrations were not
significantly increased by the co-ingestion of milk with the
HFC meal. This fact supports the above-mentioned hypothesis:
other factors, such as lactoferrin and lactoferricin, could
suppress, or at least mitigate, the endotoxin-induced release of
inflammatory markers such as IL-6.
Using an indwelling venous catheter for blood sampling may
have influenced postprandial IL-6 results. Several studies have
suggested that indwelling catheters may time-dependently
cause increases in IL-6 concentrations due to local inflammatory
response(42–45). However, Mohamed-Ali et al.(46) found no
significant blood-sampling effect on IL-6 concentrations
comparing indwelling catheter and repeated venepuncture,
and another study found no postprandial increase in IL-6
concentrations despite the use of a catheter(47). Additionally,
Schwander et al.(12) demonstrated a dose–response of post-
prandial IL-6 on energy intake with high-fat meals using an
indwelling venous catheter. Thus, there are more influencing
factors on postprandial IL-6 concentrations than only local
inflammation, and diet seems one of them. Although the
postprandial IL-6 concentrations may have to be looked at
with caution, comparing IL-6 response between meals should
not be hampered.
The age range of the participants was quite wide (25–55
years). However, comparing the data of participants aged
between 25 and 40 years with participants aged between
41 and 55 years did not show significant differences in
metabolic and inflammatory responses, except for glucose
levels that were overall higher in the older age group. Since
the study was not laid out to investigate age-related differ-
ences between meals, subgroups were too small for further
statistical evaluation.
To our knowledge, the present study is the first to compare
the influence of high-fat dairy and non-dairy meals on post-
prandial inflammatory response. However, the study has
some limitations that need to be addressed. First, postprandial
blood sampling started at 1 h after test meals, which might be
too late for observing certain metabolic reactions. For
example, van Meijl & Mensink(35) documented maximally
increased glucose concentrations at 15 and 30 min after differ-
ent test meals. This early response was missed in the present
study. However, glucose concentration was not our main par-
ameter, and starting at 1 h or even 2 h postprandially is
common(13,36,48). Second, only male subjects were enrolled
in the study, to avoid confounding effects of the female men-
strual cycle. Third, IL-6, TNF-a and endotoxin concentrations
were determined only at 0 and 6 h. However, Schwander
et al.(12) did not find significant differences in the values
between time points 2, 4 and 6 h for these parameters. The
time point 6 h after meal should therefore adequately reflect
the postprandial response. Fourth, the energy content of the
test meals differed; however, this had the advantage that the
dose–response effect documented in the previous study(12)
did not distort the results. Finally, Schwander et al.(12)
reported that apart from insulin, an energy dose–response
relationship was necessary to differentiate the postprandial
metabolic responses of obese subjects from the responses of
normal-weight subjects. Thus, we cannot exclude that an
energy dose–response design would have allowed better
differentiation of the metabolic and inflammatory responses
of the subjects to the three high-fat meals investigated. Such
complex designs remain, however, impracticable in
cross-over studies, as the number of meals to be ingested by
subjects under controlled conditions would dramatically
increase. An alternative approach that we are currently
taking is to broaden the scope of blood-derived markers that
are measured postprandially, by implementing metabolomic
and transcriptomic analytical strategies.
In conclusion, the present study indicates that the ingestion
of dairy products does not have a positive impact on
postprandial inflammation compared with an isoenergetic
high-fat non-dairy meal and neither does the addition of
full-fat milk to a high-fat meal.
Supplementary material
To view supplementary material for this article, please visit
http://dx.doi.org/10.1017/S0007114515000677
Acknowledgements
The authors thank Marie-Jeanne Voirol (CHUV, Lausanne,
Switzerland) for measuring TNF-a and IL-6 concentrations.
The present study was part of the NutriChip project, which
was financially supported by the Swiss Federal Program
Dairy products and postprandial inflammation 1859
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
NanoTera.ch. G. V. is a member of COST FA 1005 INFOGEST
‘Improving Health Properties of Food by Sharing our Knowl-
edge on the Digestive Process’.
The authors’ responsibilities were as follows: G. V. con-
ceived the research programme with input from M. A. M. G.;
A. S. designed the study with input from B. W., D. G., M. C.,
K. L. and G. V.; A. S., N. P., B. W. and D. G. planned and
conducted the study, including the randomisation procedure,
the enrolment of the subjects and their assignment to the inter-
ventions; K. L. provided the infrastructure for the intervention
study; P. G. M. designed and conducted the endotoxin
analyses; N. V. and F. P. P. designed and conducted the
TNF-a and IL-6 analyses; W. L. and U. B. conducted the
statistical analyses; A. S., U. B. and G. V. analysed the data
and the statistical reports; A. S. wrote the paper. All authors
read, commented and approved the final manuscript.
The authors declare that they have no conflict of interest.
References
1. Hotamisligil GS (2006) Inflammation and metabolic
disorders. Nature 444, 860–867.
2. Ye J & Keller JN (2010) Regulation of energy metabolism by
inflammation: a feedback response in obesity and calorie
restriction. Aging (Albany NY) 2, 361–368.
3. Klop B, Proctor SD, Mamo JC, et al. (2012) Understanding post-
prandial inflammation and its relationship to lifestyle behaviour
and metabolic diseases. Int J Vasc Med 2012, 947417.
4. Margioris AN (2009) Fatty acids and postprandial inflam-
mation. Curr Opin Clin Nutr Metab Care 12, 129–137.
5. Dandona P, Ghanim H, Chaudhuri A, et al. (2010) Macronu-
trient intake induces oxidative and inflammatory stress:
potential relevance to atherosclerosis and insulin resistance.
Exp Mol Med 42, 245–253.
6. Calder PC, Ahluwalia N, Brouns F, et al. (2011) Dietary
factors and low-grade inflammation in relation to overweight
and obesity. Br J Nutr 106, S5–S78.
7. Nappo F, Esposito K, Cioffi M, et al. (2002) Postprandial
endothelial activation in healthy subjects and in type 2
diabetic patients: role of fat and carbohydrate meals. J Am
Coll Cardiol 39, 1145–1150.
8. Tsai W, Li Y, Lin C, et al. (2004) Effects of oxidative stress on
endothelial function after a high-fat meal. Clin Sci 106,
315–319.
9. Aljada A, Mohanty P, Ghanim H, et al. (2004) Increase in
intranuclear nuclear factor kB and decrease in inhibitor kB
in mononuclear cells after a mixed meal: evidence for a
proinflammatory effect. Am J Clin Nutr 79, 682–690.
10. Havel RJ (1994) Postprandial hyperlipidemia and remnant
lipoproteins. Curr Opin Lipidol 5, 102–109.
11. Miller M, Zhan M & Georgopoulos A (2003) Effect of desir-
able fasting triglycerides on the postprandial response to
dietary fat. J Investig Med 51, 50–55.
12. Schwander F, Kopf-Bolanz KA, Buri C, et al. (2014) A dose–
response strategy reveals differences between normal-
weight and obese men in their metabolic and inflammatory
responses to a high-fat meal. J Nutr 144, 1517–1523.
13. Ghanim H, Sia CL, Upadhyay M, et al. (2010) Orange juice
neutralizes the proinflammatory effect of a high-fat, high-
carbohydrate meal and prevents endotoxin increase and
Toll-like receptor expression. Am J Clin Nutr 91, 940–949.
14. Burton-Freeman B, Talbot J, Park E, et al. (2012) Protective
activity of processed tomato products on postprandial
oxidation and inflammation: a clinical trial in healthy
weight men and women. Mol Nutr Food Res 56, 622–631.
15. Panagiotakos DB, Pitsavos CH, Zampelas AD, et al. (2010)
Dairy products consumption is associated with decreased
levels of inflammatory markers related to cardiovascular
disease in apparently healthy adults: the ATTICA Study.
J Am Coll Nut 29, 357–364.
16. Esmaillzadeh A & Azadbakht L (2010) Dairy consumption
and circulating levels of inflammatory markers among
Iranian women. Public Health Nutr 13, 1395–1402.
17. Salas-Salvado´ J, Garcia-Arellano A, Estruch R, et al. (2008)
Components of the Mediterranean-type food pattern and
serum inflammatory markers among patients at high risk
for cardiovascular disease. Eur J Clin Nutr 62, 651–659.
18. Bordoni A, Danesi F, Dardevet D, et al. (2015) Dairy pro-
ducts and inflammation: a review of the clinical evidence.
Crit Rev Environ Sci Technol (In the Press).
19. Zemel MB, Donnelly JE, Smith BK, et al. (2008) Effects of
dairy intake on weight maintenance. Nutr Metab 5, 28–41.
20. Labonte´ ME, Couture P, Richard C, et al. (2013) Impact of
dairy products on biomarkers of inflammation: a systematic
review of randomized controlled nutritional intervention
studies in overweight and obese adults. Am J Clin Nutr 97,
706–717.
21. Nestel PJ, Pally S, MacIntosh GL, et al. (2012) Circulating
inflammatory and atherogenic biomarkers are not increased
following single meals of dairy foods. Eur J Clin Nutr 66,
25–31.
22. Creely SJ, McTernan PG, Kusminski CM, et al. (2007) Lipopo-
lysaccharide activates an innate immune system response
in human adipose tissue in obesity and type 2 diabetes.
Am J Physiol Endocrinol Metab 292, E740–E747.
23. R Core Team (2013) R: A Language and Environment for
Statistical Computing. Vienna: R Foundation for Statistical
Computing. http://www.R-project.org/
24. Jones B & Kenward MG (2003) Design and Analysis of Cross-
Over Trials, 2nd ed. Boca Raton, FL: Chapman & Hall/CRC.
25. Zemel MB & Sun X (2008) Dietary calcium and dairy pro-
ducts modulate oxidative and inflammatory stress in mice
and humans. J Nutr 138, 1047–1052.
26. Legrand D (2012) Lactoferrin, a key molecule in immune and
inflammatory processes. Biochem Cell Biol 90, 252–268.
27. Mattsby-Baltzer I, Roseanu A, Motas C, et al. (1996) Lactofer-
rin or a fragment thereof inhibits the endotoxin-induced
interleukin-6 response in human monocytic cells. Pediatr
Res 40, 257–262.
28. Jemima EA, Prema A & Thangam EB (2014) Functional
characterization of histamine H4 receptor on human mast
cells. Mol Immunol 62, 19–28.
29. Weiss C (2009) Biogene amine. Erna¨hrungs-Umschau 56,
172–179.
30. Harte AL, Varma MC, Tripathi G, et al. (2012) High fat intake
leads to acute postprandial exposure to circulating endo-
toxin in type 2 diabetic subjects. Diabetes Care 35, 375–382.
31. Moreira APB, Texeira TFS, Ferreira AB, et al. (2012) Influence
of a high-fat diet on gut microbiota, intestinal permeability
and metabolic endotoxaemia. Br J Nutr 108, 801–809.
32. Erridge C, Attina T, Spickett CM, et al. (2007) A high-fat meal
induces low-grade endotoxemia: evidence of a novel mech-
anism of postprandial inflammation. Am J Clin Nutr 86,
1286–1292.
33. van Oostrom AJ, Rabelink TJ, Verseyden C, et al. (2004)
Activation of leukocytes by postprandial lipemia in healthy
volunteers. Atherosclerosis 177, 175–182.
A. Schmid et al.1860
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
34. Sun Q, Li J & Gao F (2014) New insights into insulin: the
anti-inflammatory effect and its clinical relevance. World J
Diabetes 5, 89–96.
35. van Meijl LEC & Mensink RP (2013) Effects of milk and milk
constituents on postprandial lipid and glucose metabolism in
overweight and obese men. Br J Nutr 110, 413–419.
36. Clemente G, Mancini M, Nazzaro F, et al. (2003) Effects of
different dairy products on postprandial lipemia. Nutr
Metab Cardiovasc Dis 13, 377–383.
37. Dubois C, Beaumier G, Juhel C, et al. (1998) Effects of
graded amounts (0–50 g) of dietary fat on postprandial lipe-
mia and lipoproteins in normolipidemic adults. Am J Clin
Nutr 67, 31–38.
38. Lopez-Miranda J, Williams C & Lairon D (2007) Dietary,
physiological, genetic and pathological influences on post-
prandial lipid metabolism. Br J Nutr 98, 458–473.
39. Zemel MB (2009) Proposed role of calcium and dairy food
components in weight management and metabolic health.
Phys Sportsmed 37, 29–39.
40. Denke MA, Fox MM & Schulte MC (1993) Short-term dietary
calcium fortification increases fecal saturated fat content and
reduces serum lipids in men. J Nutr 123, 1047–1053.
41. Clemente-Postigo M, Queipo-Ortuno MI, Murri M, et al.
(2012) Endotoxin increase after fat overload is related to
postprandial hypertriglyceridemia in morbidly obese
patients. J Lipid Res 53, 973–978.
42. Dixon NC, Hurst TL, Talbot DCS, et al. (2009) Active
middle-aged men have lower fasting inflammatory markers
but the postprandial inflammatory response is minimal and
unaffected by physical activity status. J Appl Physiol 107,
63–68.
43. Seiler W, Mu¨ller H & Hiemke C (1994) Interleukin-6 in
plasma collected with an indwelling cannula reflects local,
not systemic, concentrations. Clin Chem 40, 1778–1779.
44. Gudmundsson A, Ershler WB, Goodman B, et al. (1997)
Serum concentrations of interleukin-6 are increased when
sampled through an indwelling venous catheter. Clin
Chem 43, 2199–2201.
45. Haack M, Kraus T, Schuld A, et al. (2002) Diurnal variations
of inteleukin-6 plasma levels are confounded by blood
drawing procedures. Psychoneuroendocrinology 27,
921–931.
46. Mohamed-Ali V, Goodrick S, Rawesh A, et al. (1997) Subcu-
taneous adipose tissue releases interleukin-6, but not tumor
necrosis factor-a, in vivo. J Clin Endocrinol Metab 82,
4196–4200.
47. Hansen K, Sickelmann F, Pietrowsky R, et al. (1997) Systemic
immune changes following meal intake in humans. Am J
Physiol 273, R548–R553.
48. Blackburn P, Despres JP, Lamarche B, et al. (2006) Post-
prandial variations of plasma inflammatory markers in
abdominally obese men. Obesity Res 14, 1747–1754.
Dairy products and postprandial inflammation 1861
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
